Henry R. Wolfe
President, Benthic Medicines, Inc.
Thomas Jefferson University.
Greater Philadelphia Area
Biography
Dr. Wolfe has studied the Traditional Medicines of many cultures as an avocation throughout his 35 year career. At Benthic Medicines Dr. Wolfe has focused on using the tools of western pharmacology to understand the role of each ingredient used in traditional medicines. Most recently, he has used this approach to develop a novel formulation composed of ingredients utilized to prevent the formation of kidney stones in Chinese, Ayurvedic and Unani Traditional Medicines. Dr. Wolfe is currently employed as the Senior Vice President of Pharmaceutical Research and Development at Antares Pharma. He has served in various research roles developing both natural products and isolated peptides and designed proteins and small molecules within various pharmaceutical and biotechnology companies. As Chief Scientific Officer at Genaera Corporation, Dr. Wolfe conducted clinical studies on squalamine for cancer and trodusquemine for weight loss, both isolated from shark liver. Dr. Wolfe received a BA degree in Biology from Towson University, an MS in Biochemistry and Nutrition from Virginia Polytechnic Institute and a PhD in Molecular Pharmacology and Structural Biology from Thomas Jefferson University.
Research Interest
Pharmaceutical Research Molecular Pharmacology Biochemistry Nutrition Structural Biology